 Empiric therapy amphotericin febrile granulocytopenic patients early diagnosis invasive fungal infection granulocytopenic patients unreliable Granulocytopenic patients febrile therapy appropriate antibacterial agents high risk development infection randomized clinical trials empiric administration amphotericin febrile granulocytopenic patients frequency morbidity mortality invasive fungal infection effects granulocytopenic patients antifungal prophylaxis Current studies prompt empiric administration amphotericin febrile granulocytopenic patients treatment deep mycoses roles antifungal triazole compounds liposomal lipid complexes amphotericin empiric antifungal therapy clinical trials